What did Progyny (PGNY) announce about its share repurchase program on May 26, 2026?

Progyny announced a board-approved share repurchase program authorizing buybacks of up to $200 million of common stock. According to Progyny, the program provides flexibility to repurchase shares over time, subject to market conditions and other factors determined by the company.

How large is Progyny's (PGNY) new share buyback authorization?

Progyny's share repurchase authorization is up to $200 million of its common stock. According to Progyny, this authorization allows the company to repurchase shares in the open market or through Rule 10b5-1 plans, depending on stock price and market conditions.

How will Progyny (PGNY) fund its $200 million share repurchase program?

Progyny plans to fund its share repurchase program using available cash balances. According to Progyny, the company may execute repurchases in the open market, including through Rule 10b5-1 trading plans, providing discretion over timing and volume of any buybacks.

What methods can Progyny (PGNY) use to execute its share repurchases?

Progyny may repurchase shares through open market purchases, including Rule 10b5-1 trading plans. According to Progyny, execution will depend on stock price, market conditions, and other factors the company considers relevant, and the program can be adjusted or halted as needed.

Progyny, Inc. Announces Share Repurchase Program

Progyny (Nasdaq: PGNY) announced that its board approved a share repurchase program authorizing buybacks of up to $200 million of common stock.

Rhea-AI Impact

(Moderate)

Rhea-AI Sentiment

(Positive)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Progyny (Nasdaq: PGNY) announced that its board approved a share repurchase program authorizing buybacks of up to $200 million of common stock. The program will be funded with available cash and may use open-market and Rule 10b5-1 plans, with timing and size depending on market conditions.

Positive

Board authorizes up to $200 million in share repurchases
Buybacks funded from available cash balances, not new financing

Negative

Company gives no assurance on number of shares repurchased
Repurchase program may be suspended or discontinued at any time

Argus May 26 session

+0.68% close to close Open Argus

Details

News Market Reaction – PGNY

On May 26, the day this news came out, PGNY closed 0.68% above the previous close.

Data tracked by StockTitan Argus for the May 26 session.

Key Figures

New buyback authorization: $200 million Cash & securities: $225.1 million Credit facility: $200 million +3 more

New buyback authorization: $200 million; Maximum common stock repurchases under new program
Cash & securities: $225.1 million; Quarter ended March 31, 2026 (10-Q)
Credit facility: $200 million; Undrawn credit facility as of Q1 2026 (10-Q)
Completed buyback: $200 million; Prior repurchase program completed with 5.5M shares in Q1 2026 (10-Q)
Share price: $24.88; Pre-news price vs 52-week range $16.10–$28.75
Operating cash flow: $45.9 million; Q1 2026, from 8-K earnings release

Historical Context

5 past events · Latest: May 11

5 events

May 11
Conference appearance

24h Move

-4.9%

Announcement of participation in BofA Securities 2026 Health Care Conference.
May 07
Earnings results

24h Move

+23.8%

Record Q1 2026 revenue, profitability and share repurchases update.
Apr 23
Earnings date set

24h Move

-1.8%

Scheduled release date and call details for Q1 2026 results.
Apr 16
Product launch

24h Move

+3.1%

Launch of Progyny Select fully insured supplemental fertility and health plan.
Apr 01
Corporate milestone

24h Move

-0.7%

10-year anniversary highlighting membership, employer base and coverage growth.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

share repurchase program, open market repurchases, Rule 10b5-1

3 terms

open market repurchases financial

"Shares may be repurchased through open market repurchases, including through plans complying"

Open market repurchases are when a company buys its own shares back using cash by purchasing them on public stock exchanges, just like someone gradually buying slices from a shared pie so the remaining slices grow bigger. For investors this matters because repurchases lower the number of shares outstanding, which can raise earnings per share and push the stock price higher, but they also use corporate cash and signal management priorities, so the trade-offs affect valuation and risk.

Rule 10b5-1 regulatory

"including through plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

05/26/2026 - 08:00 AM EDT

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its Board of Directors has approved a share repurchase program to repurchase up to $200 million of its common stock. The program will be funded through available cash balances.

Shares may be repurchased through open market repurchases, including through plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, depending on stock price, market conditions and other factors deemed relevant in the Company’s sole discretion. The program may be suspended or discontinued at any time. There can be no assurances as to how many shares the Company will repurchase, if any, or at what prices any purchases will be made.

About Progyny

Progyny (Nasdaq: PGNY) is a global leader in women’s health and family building solutions, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients, and physicians.

Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.

Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com

Media:
Alexis Ford
media@progyny.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Is Progyny (PGNY) required to repurchase the full $200 million of shares?

Progyny is not obligated to repurchase the full $200 million of shares. According to Progyny, there can be no assurance regarding how many shares, if any, will be repurchased or at what prices, and the program may be suspended or discontinued.

Progyny, Inc. Announces Share Repurchase Program